Oncologist-approved cancer information from the American Society of Clinical Oncology

Gastrointestinal Cancers

Cetuximab Works Better than Bevacizumab as Initial Treatment for Advanced Colorectal Cancer

ASCO Annual Meeting
June 1, 2013

According to a recent study, initial treatment with the drug cetuximab (Erbitux) plus the chemotherapy regimen FOLFIRI lengthens the lives of patients with metastatic colorectal cancer when compared with bevacizumab (Avastin) plus FOLFIRI. The chemotherapy regimen FOLFIRI includes the drugs leucovorin (Wellcovorin), fluorouracil (5-FU, Adrucil), and irinotecan (Camptosar).  

Pages

© 2005-2014 American Society of Clinical Oncology (ASCO). All rights reserved worldwide.

Connect With Us: